Harry H. Yoon

7.9k total citations
98 papers, 2.2k citations indexed

About

Harry H. Yoon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Harry H. Yoon has authored 98 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 54 papers in Surgery. Recurrent topics in Harry H. Yoon's work include Gastric Cancer Management and Outcomes (49 papers), Esophageal Cancer Research and Treatment (42 papers) and Cancer Immunotherapy and Biomarkers (34 papers). Harry H. Yoon is often cited by papers focused on Gastric Cancer Management and Outcomes (49 papers), Esophageal Cancer Research and Treatment (42 papers) and Cancer Immunotherapy and Biomarkers (34 papers). Harry H. Yoon collaborates with scholars based in United States, South Korea and Japan. Harry H. Yoon's co-authors include Frank A. Sinicrope, Qian Shi, Zhaohui Jin, Daniel J. Sargent, Steven R. Alberts, Yoon‐Koo Kang, Robert B. Diasio, Stephen N. Thibodeau, Daniel V.T. Catenacci and Zev A. Wainberg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Harry H. Yoon

90 papers receiving 2.2k citations

Peers

Harry H. Yoon
Catherine Julié France
Radka Obermannová Czechia
Masashi Wakabayashi Japan
Takeru Wakatsuki Japan
Hirofumi Yasui Japan
Jacek Pachlewski Poland
Javier Martínez‐Trufero Spain
Heung Moon Chang South Korea
Antoine Adenis France
Wasat Mansoor United Kingdom
Catherine Julié France
Harry H. Yoon
Citations per year, relative to Harry H. Yoon Harry H. Yoon (= 1×) peers Catherine Julié

Countries citing papers authored by Harry H. Yoon

Since Specialization
Citations

This map shows the geographic impact of Harry H. Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry H. Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry H. Yoon more than expected).

Fields of papers citing papers by Harry H. Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry H. Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry H. Yoon. The network helps show where Harry H. Yoon may publish in the future.

Co-authorship network of co-authors of Harry H. Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Harry H. Yoon. A scholar is included among the top collaborators of Harry H. Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry H. Yoon. Harry H. Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naqvi, Syed Arsalan Ahmed, Zhaohui Jin, Harry H. Yoon, et al.. (2025). Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis. The Oncologist. 30(8). 2 indexed citations
2.
3.
Pai, Rish K., Mitesh J. Borad, Hao Xie, et al.. (2025). Immune Checkpoint Inhibitors for Mismatch Repair–Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic. JCO Precision Oncology. 9(9). e2500492–e2500492.
4.
Su, David, Beatrice J. Sun, Kiran K. Turaga, et al.. (2025). Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer. 131(13). e35870–e35870.
5.
6.
Catenacci, Daniel V.T., Minori Koshiji Rosales, Hyun Cheol Chung, et al.. (2021). P-138 Margetuximab combined with anti-PD-1 (retifanlimab) or anti-PD-1/LAG-3 (tebotelimab) +/- chemotherapy in first-line therapy of advanced/metastatic HER2+ gastroesophageal junction or gastric cancer. Annals of Oncology. 32. S146–S146. 1 indexed citations
7.
Sonbol, Mohamad Bassam, et al.. (2021). Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis. Frontiers in Oncology. 11. 641044–641044. 2 indexed citations
8.
Childs, Daniel S., et al.. (2020). Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Supportive Care in Cancer. 29(2). 733–739. 3 indexed citations
9.
Catenacci, Daniel V.T., Minori Koshiji Rosales, Hyun Cheol Chung, et al.. (2020). MAHOGANY: Margetuximab Combination in HER2+ Unresectable/metastatic Gastric/gastroesophageal Junction Adenocarcinoma. Future Oncology. 17(10). 1155–1164. 81 indexed citations
10.
Yoon, Harry H., Qian Shi, Erica N. Heying, et al.. (2018). Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis. Clinical Cancer Research. 25(1). 125–133. 63 indexed citations
11.
Wainberg, Zev A., Shadia I. Jalal, Kei Muro, et al.. (2017). KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer. Annals of Oncology. 28. v616–v617. 30 indexed citations
12.
Yoon, Harry H., Mark A. Lewis, Nathan R. Foster, et al.. (2016). Central nervous system relapse in patients with untreated HER2‐positive esophageal or gastroesophageal junction adenocarcinoma. International Journal of Cancer. 139(7). 1626–1631. 10 indexed citations
13.
Sinicrope, Frank A., Michelle R. Mahoney, Harry H. Yoon, et al.. (2015). Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance). Clinical Cancer Research. 21(23). 5294–5304. 66 indexed citations
14.
Yoon, Harry H., Chang‐Il Kwon, Seok Jeong, et al.. (2015). Clinical Significance of Biliary Dilatation and Cholelithiasis after Subtotal Gastrectomy. Korean Journal of Gastroenterology. 66(1). 33–33. 4 indexed citations
15.
Yoon, Harry H., Qian Shi, William R. Sukov, et al.. (2012). Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas. Clinical Cancer Research. 18(2). 546–554. 116 indexed citations
16.
Yoon, Harry H., Mark A. Lewis, Qian Shi, et al.. (2011). Prognostic Impact of Body Mass Index Stratified by Smoking Status in Patients With Esophageal Adenocarcinoma. Journal of Clinical Oncology. 29(34). 4561–4567. 60 indexed citations
17.
Yoon, Harry H., et al.. (2011). Intravesical Cidofovir in the Treatment of Hemorrhagic Cystitis after Unrelated Cord Blood Transplantation. The Korean Journal of Internal Medicine. 81(5). 663–666.
18.
Yoon, Harry H., Val J. Lowe, Stephen D. Cassivi, & Yvonne Romero. (2009). The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction. Gastroenterology Clinics of North America. 38(1). 105–120. 4 indexed citations
19.
Chung, Gina G., Harry H. Yoon, Maciej P. Zerkowski, et al.. (2006). Vascular endothelial growth factor, FLT‐1, and FLK‐1 analysis in a pancreatic cancer tissue microarray. Cancer. 106(8). 1677–1684. 54 indexed citations
20.
Yoon, Harry H., Gina G. Chung, Malini Harigopal, et al.. (2004). Quantitative immunohistochemical analysis of VEGF expression on a pancreatic cancer tissue microarray. Cancer Research. 64. 96–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Julié Breakdown of academic impact, for papers by Radka Obermannová Breakdown of academic impact, for papers by Masashi Wakabayashi Breakdown of academic impact, for papers by Takeru Wakatsuki Breakdown of academic impact, for papers by Hirofumi Yasui Breakdown of academic impact, for papers by Jacek Pachlewski Breakdown of academic impact, for papers by Javier Martínez‐Trufero Breakdown of academic impact, for papers by Heung Moon Chang Breakdown of academic impact, for papers by Antoine Adenis Breakdown of academic impact, for papers by Wasat Mansoor
Rankless by CCL
2026